Stay updated on Avelumab Entinostat in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab Entinostat in Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedFallopian tube cancer was added to the conditions list, and the page revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page now displays Revision: v3.4.1 instead of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedA glossary display option was added, and page metadata was updated to include 'Last Update Submitted that Met QC Criteria,' 'No FEAR Act Data,' and revision note v3.4.0.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check68 days agoChange DetectedA consolidated Locations section lists study sites across Florida, Illinois, Maryland, Massachusetts, Missouri, New York, Pennsylvania, Tennessee, and Virginia. The page updates to revision v3.3.3 by replacing the previous state-specific location subsections from v3.3.2.SummaryDifference0.9%

- Check89 days agoChange DetectedThe page shows a new revision label (v3.3.2) and removes the previous label (v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Avelumab Entinostat in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.